Authors


Barbara J. McNeil, MD

Latest:

GRACE Principles: Recognizing High-Quality Observational Studies of Comparative Effectiveness

The GRACE principles lay out 3 questions to help healthcare providers, patients, and other decision makers evaluate the quality of noninterventional comparative effectiveness studies.



Caroline F. Pearson

Latest:

Patient Access to Oncology Care in ACA Exchange Plans

This article describes provider networks and benefit design-including deductibles, cost-sharing, and maximum out-of-pocket limits-for oncology care in 2015 health insurance exchanges.



Sim&oacute

Latest:

Impact of Statin Guidelines on Statin Utilization and Costs in an Employer-Based Primary Care Clinic

Adherence to clinical guidelines in practice is often suboptimal and controversial. This study compares actual statin utilization and cost with full adoption of major clinical guidelines in a real-world population.


Lisa Mucha, PhD

Latest:

Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics

Higher cost sharing is associated with reduced branded antidepressant initiation among patients trying generic therapy. Dynamic benefit designs could enhance access to branded medications when appropriate.


J&uuml

Latest:

Value-Based Payment in Implementing Evidence-Based Care: The Mental Health Integration Program in Washington State

Value-based payment improved fidelity to key elements of the Collaborative Care Model—an evidence-based mental health intervention—and improved patient depression outcomes in Washington state.






Andy N. Garman, PsyD

Latest:

Empirical Analysis of Domestic Medical Travel for Elective Cardiovascular Procedures

Promoting domestic medical travel to high-quality providers could improve clinical outcomes and reduce long-term healthcare costs.


Jennifer S. Shin, PharmD

Latest:

Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program

This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life.



Milesh Patel, MS

Latest:

Disparities in Diabetes and Hypertension Care for Individuals With Serious Mental Illness

This study highlights disparities in care for diabetes and hypertension for individuals with serious mental illness compared with the general Medicaid and Medicare populations.


Scott A. Fox, MS, MEd

Latest:

Collaborative DTM Reduces Hospitalization and Healthcare Costs in Patients With Diabetes Treated With Polypharmacy

Drug therapy management implementation in 2 health plans resulted in significant cost savings and modest to significant reductions in emergency department visits and inpatient admissions among patients with diabetes.


Katie Eder, Senior Editor, Pharmacy Times

Latest:

The Clinical Core of the JNC 8 Hypertension Guidelines

The latest Joint National Committee guidelines are based on 27 large clinical trials concerning hypertension management. These trials are often discussed in isolation, but their data have never been aggregated into a single source.


James M. Pitcavage, MSPH

Latest:

The Value of Value-Based Insurance Design: Savings From Eliminating Drug Co-Payments

Geisinger Health System’s $0 co-pay drug program for its chronically ill employee population is associated with positive cost savings and a 5-year return-on-investment of approximately 1.8.



Melissa S. Stahl, MPH

Latest:

Unintended Consequences of a Quality Measure for Acute Bronchitis

A quality measure reduced antibiotic use for patients with acute bronchitis but led to use of an alternative diagnosis, offsetting most of the observed improvement.


Alejandro Amill-Rosario, MPH

Latest:

Health Information Technology for Ambulatory Care in Health Systems

Health systems are important in driving electronic health record adoption in ambulatory clinics, although the uptake of key functionalities varies across systems.



Brian Meissner, PharmD, PhD

Latest:

Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence

Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.





Chandra Y. Osborn, PhD, MPH

Latest:

Leveling the Field: Addressing Health Disparities Through Diabetes Disease Management

A subanalysis of a successful algorithm-driven primary care–based diabetes disease management program examines the relationships among patient characteristics, labor inputs, and improvement in A1C level.


Robert Brook, MD, ScD

Latest:

Results From a National Survey on Chronic Care Management by Health Plans

This study shows that health plans use chronic care management programs as standard components of the overall approach to manage the health of their members.


Kenneth A. Lawson, PhD

Latest:

Comprehensive Health Management Pharmacist-Delivered Model: Impact on Healthcare Utilization and Costs

Pharmacist-provided comprehensive medication management led to a significant difference in emergency department visits and a cost savings of $2.10 to $2.60 for every $1.00 spent relative to a comparator group.


Dana El Hajj, BSN, RN

Latest:

Effects of Telephone Counseling on Antipsychotic Adherence and Emergency Department Utilization

A telehealth nursing program used psychological counseling techniques to improve antipsychotic medication adherence, leading to reduced emergency department utilization in a managed Medicaid population.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo